Neurocognitive similarities between severe chronic schizophrenia and behavioural variant frontotemporal dementia.

Psychiatry Res

Neuropsychiatry Unit, John Cade Level 2, Royal Melbourne Hospital, Parkville 3050, VIC, Australia; Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne & Melbourne Health, Parkville 3053, VIC, Australia.

Published: February 2015

This study focuses on a group of patients with chronic schizophrenia who have a more severe form of the disorder, as indicated by socio-functional decline, treatment resistance, and recurrent hospitalisation. Previous research has suggested that the pattern and severity of cognitive deficits in people with severe chronic schizophrenia is similar to that observed in behavioural variant frontotemporal dementia (bvFTD). In the current study, we compared neurocognitive performance in 16 cognitive domains in 7 inpatients with severe chronic schizophrenia, 13 community-dwelling outpatients with chronic schizophrenia, 12 patients with bvFTD, and 18 healthy controls. Our findings revealed more similar cognitive profiles between the schizophrenia inpatient and bvFTD groups compared to the schizophrenia outpatient group, who outperformed the former groups. The current results provide preliminary evidence for a distinct schizophrenia subgroup, distinguishable from other chronic schizophrenia patients by poorer clinical and functional status, who have levels of cognitive impairment comparable to those seen in bvFTD patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2014.11.029DOI Listing

Publication Analysis

Top Keywords

chronic schizophrenia
24
severe chronic
12
schizophrenia
9
behavioural variant
8
variant frontotemporal
8
frontotemporal dementia
8
schizophrenia patients
8
chronic
6
neurocognitive similarities
4
severe
4

Similar Publications

The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation.

Schizophrenia (Heidelb)

January 2025

Xinjiang Clinical Medical Research Center of Mental Health, State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, The Psychological Medicine Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.

Oxidative stress (OS) is crucial in schizophrenia (SCZ) pathology. Ferroptosis, a recently discovered cell death pathway linked to OS, might contribute to the development of SCZ. This study investigated the association between ferroptosis markers and cognitive impairments in chronic SCZ patients.

View Article and Find Full Text PDF

Neurofilament Light Protein as a Biomarker in Severe Mental Disorders: A Systematic Review.

Int J Mol Sci

December 2024

Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy.

Severe mental disorders (SMDs), such as schizophrenia (SZ), bipolar disorder (BD), and major depressive disorder (MDD), are heterogeneous psychiatric diseases that impose a significant societal burden due to their chronic disabling nature. There are no objective and reliable diagnostic tests for SMDs; thus, there is an urgent need for specific biomarkers to improve diagnosis, treatment, and resource allocation. Neurofilaments, found in cerebrospinal fluid and blood, offer reliable diagnostic and prognostic potential.

View Article and Find Full Text PDF

This study aimed to determine the association between chronic schizophrenia, extrapyramidal symptoms (EPSs), body composition, nutritional status, and dynapenia/sarcopenia. Data from 68 chronic patients with schizophrenia were analyzed using Spearman's rho correlation coefficients, Kruskal-Wallis test, Mann-Whitney U test, and Cramér's V statistics. Among the participants, 32.

View Article and Find Full Text PDF

Schizophrenia is a complex disorder with no known single cause which makes family caregivers of patients to develop their own perceptions and interpretations of the condition. We aimed to find out family caregivers' perceptions and how they influence their treatment seeking behavior as well as attitudes of community members toward family caregivers and their patients. Qualitative data were collected from 24 family caregivers, of patients with schizophrenia who were residents of Greater Kampala Metropolitan Area.

View Article and Find Full Text PDF

Background/objectives: Schizophrenia is a chronic psychiatric disorder usually managed with antipsychotics, which can cause adverse drug reactions (ADRs) that may impact patients' attitudes toward their treatment, as well as treatment adherence. This study aimed to assess the influence of ADRs and other factors on treatment attitudes among female patients with schizophrenia.

Methods: A cross-sectional study was conducted at the Vrapče Psychiatry Clinic with 109 female schizophrenia patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!